Director Declaration

Summary by AI BETAClose X

Costain Group PLC has announced that Fiona MacAulay, a Non-Executive Director, has become an independent director of Dauch Corporation, which is listed on both the London and New York Stock Exchanges, effective from 3 February 2026, following the completion of the acquisition and merger of Dowlais Group plc into Dauch Corporation. This appointment follows her retirement from the Board of Chemring Group PLC on 20 February 2026, where she did not seek re-election.

Disclaimer*

Costain Group PLC
24 February 2026
 

 

Image 

Costain Group PLC (Costain)

24 February 2026

 

 

External Appointment

 

Costain confirms that, as announced by Chemring Group PLC (Chemring), on 10 November 2025. Fiona MacAulay, a Non-Executive Director of Costain, Chair of the Remuneration Committee and member of the Audit and Risk Committee and Nomination Committee, did not seek re-election at the Chemring AGM on 20 February 2026 and has therefore retired from the Board of Chemring.

 

Additionally, in accordance with UK Listing Rule 6.4.9R(2), Costain has been advised that following the completion of the acquisition and merger of Dowlais Group plc into Dauch Corporation (formally American Axel & Manufacturing), Fiona became an independent director of Dauch Corporation, which is listed on the London Stock Exchange and the New York Stock Exchange with effect from 3 February 2026.

 

Enquiries


 

Investors and analysts

matt.jones@costain.com

Matthew Jones, Costain

+44 (0) 7860 922 341



Company Secretariat

costaincosec@costain.com

Katie Mullins

+44 (0) 7353 006 675

Cyd Trumper

+44 (0) 7879 133 084


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings